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Our objective was to improve current knowledge of sporadic (Spo) nosocomial
Acinetobacter calcoaceticus-Acinetobacter baumannii (Acb) complex populations, and
thus better understand the epidemiology of Spo and endemoepidemic (EE) strains.
Between 1999 and 2010, 133 isolates of Spo Acb complex were obtained from a single
hospital. Species were identified by gyrB-PCR, and via gyrB- and rpoB-sequencing.
Clonal analysis was undertaken using pulsed-field gel electrophoresis (PFGE) and
multilocus sequence typing. Susceptibility to antimicrobial agents was determined by
microdilution and E-tests. Carbapenemase genes were detected by PCR. One hundred
and one PFGE types were detected. A. baumannii was the most common (67/101
PFGE types), followed by Acinetobacter pittii (22/101), Acinetobacter lactucae (6/101),
and Acinetobacter calcoaceticus (2/101). gyrB, rpoB1, and rpoB2 sequencing returned
49, 13, and 16 novel sequences, respectively. Sixty-three sequence types (STs) (38
new STs and 66 new alleles) were detected; the most common were ST2 (29/133
isolates) and ST132 (14/133). Twenty-six OXA-51 allelic variants were detected, nine of
which were novel. The PFGE types were generally susceptible (88/101) to all the tested
antimicrobials; 3/101 were carbapenem-resistant due to the presence of the genetic
structure ISAba2-blaOXA-58-like-ISAba3, and 2/101 were multidrug-resistant. It can be
concluded that the examined Spo Acb complex population was mainly composed of
A. baumannii. Many different clones were detected (with ST2 clearly dominant), all largely
susceptible to antimicrobials; multidrug resistance was rare. In contrast, a previously
examined EE Acb population was composed of just four expanding, multidrug-resistant
A. baumannii clones -ST2, ST3, ST15, and ST80-.
Keywords: Acinetobacter calcoaceticus-baumannii complex, sporadic strains, epidemic strains, species
identification, clonal distribution, antimicrobial susceptibility
Abbreviations: Acb, Acinetobacter calcoaceticus – Acinetobacter baumannii; CC, clonal complex; CHO, carbapenem-
hydrolysing oxacillinase; EE, endemoepidemic; MBL, metallo-beta-lactamase; MDR, multidrug resistance; MLST, multilocus
sequence typing; MST, minimum spanning tree; PFGE, pulsed-field gel electrophoresis; Spo, sporadic; ST, sequence type.
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INTRODUCTION
The Acb complex has traditionally been regarded as formed
by four Acinetobacter species: Acinetobacter calcoaceticus,
Acinetobacter baumannii, Acinetobacter nosocomialis, and
Acinetobacter pittii (Gerner-Smidt et al., 1991; Nemec et al.,
2011). Other genomic species were later proposed for inclusion,
including Acinetobacter seifertii [formerly Acinetobacter genomic
species “close to 13TU” (Gerner-Smidt and Tjiernberg, 1993;
Nemec et al., 2015)], A. lactucae (formerly Acinetobacter NB14
and synonym of A. dijkshoorniae (Espinal et al., 2015; Cosgaya
et al., 2016; Rooney et al., 2016; Dunlap and Rooney, 2018),
and the Acinetobacter genomic species “between 1 and 3.”
All the species of the complex are genetically closely related
and phenotypically indistinguishable; molecular methods are
required for accurate identifications (Gerner-Smidt et al., 1991).
Acinetobacter baumannii is the species most frequently
involved in nosocomial and community-acquired infections,
followed by A. pittii and A. nosocomialis (Peleg et al., 2008).
A. calcoaceticus has chiefly been isolated from environmental
sources, such as soil and water, and its participation in
clinical infections remains unclear. A. seifertii, A. lactucae, and
Acinetobacter gen. species “between 1 and 3” have also been
isolated from clinical specimens (Peleg et al., 2008; Nemec et al.,
2015; Cosgaya et al., 2016).
Carbapenem-resistant A. baumannii has been involved in
numerous nosocomial outbreaks around the world (Peleg et al.,
2008; Higgins et al., 2010a; Antunes et al., 2014). This resistance
is mainly determined by CHOs: OXA-23, OXA-40, and OXA-
58) and less frequently by MBLs (Poirel and Nordmann, 2006;
Peleg et al., 2008). At least eight A. baumannii CCs have been
internationally disseminated, being CC1, CC2, and CC3 the
most representative (Diancourt et al., 2010; Higgins et al., 2010a;
Karah et al., 2012).
Sporadic and epidemic nosocomial strains of the Acb
complex share the same ecological niche but show significant
epidemiological differences. While the epidemic strains cause
outbreaks (Peleg et al., 2008), the Spo strains are involved in the
infection of individual patients, and for this reason have rarely
been studied in any depth (Sonnevend et al., 2013; Selasi et al.,
2016; Tomaschek et al., 2016).
The aim of the present work was to improve our knowledge
of Spo nosocomial Acb complex populations, and thus better
understand the epidemiology of the Spo strains in respect to
the EE strains. The Spo population of the Acb complex at a
single hospital over a 12-year period was characterized (species
identification, clonal analysis, antimicrobial susceptibility, and
carbapenem-resistance) and compared to its previously analyzed
EE population (Villalón et al., 2015).
MATERIALS AND METHODS
Background and Study Design
Three hundred and sixty-four Acb complex isolates were
collected from a single tertiary care hospital during nosocomial
outbreaks and interepidemic periods between 1999 and 2010.
The clinical samples were taken as part of standard patient care.
The bacterial isolates were involved in infectious diseases -except
those obtained from screening of carriers and environmental
sampling-, were previously identified by biochemical methods
in the hospital and were sent to the Spanish National Centre
for Microbiology (CNM) for their molecular characterization.
All isolates were analyzed by PFGE, and 15 EE PFGE
types (EE1 to EE15, 231 isolates) (Villalón et al., 2015)
and 101 Spo PFGE types (Spo1 to Spo101, 133 isolates)
obtained. Later, one representative isolate from each PFGE
type was analyzed.
In a previous work (Villalón et al., 2015), we analyzed the
15 EE PFGE types. Now, this study shows three novelties in
relation to that former work. First, we identified the species
of the whole Acb complex population –i.e., Spo and EE PFGE
types- using different molecular methods. Second, we undertook
the molecular analysis of the 101 Spo PFGE types. Third, we
compared the results from the Spo population with the preceding
results (Villalón et al., 2015) from the EE population.
Some key molecular terms used within this study are
next defined (Field et al., 2014): PFGE type or strain: a
group of pathogens that share the same PFGE pattern. All
distinguishable PFGE patterns were interpreted as different
PFGE types or strains. Hereafter, the term “PFGE type” will
be used. EE PFGE type: PFGE type that had ≥5 isolates
from the same hospital ward at the same time, or PFGE
type that although had <5 isolates showed ≥85% genetic
similarity with any former PFGE type (Villalón et al., 2015).
Spo PFGE type: PFGE type that did not fit into the EE
definition. Isolate: each pure bacterial culture that was sent to
the CNM for its analysis. This study included only one isolate
per patient and infectious episode. Clone or ST: a group of
PFGE types that shared the same MLST allelic profile. CC:
a cluster of STs that showed one allele difference maximum
(Diancourt et al., 2010).
Categorical variables were compared using the Chi-squared
test with Mantel-Haenszel correction. Significance was set at
p ≤ 0.05. All statistical analyses were performed using Epi
Info software1.
Molecular Identification of Acinetobacter
Species: gyrB, rpoB, and blaOXA-51-like
Genes
PCR-amplification of gyrB polymorphisms was used to identify
A. baumannii (294 and 490 bp fragments), A. calcoaceticus
(428 bp), A. nosocomialis (294 bp), and A. pittii (194 bp);
an additional 1194 bp fragment could also be obtained for
A. calcoaceticus, A. nosocomialis, and A. pittii isolates (Higgins
et al., 2007, 2010b). Sequencing of a gyrB 906 bp fragment
was performed as described by the Clinical and Laboratory
Standards Institute (CLSI) (Clinical and Laboratory Standards
Institute, 2008). In addition, two hypervariable rpoB-fragments
here named rpoB1 (zone 1, 351 bp) and rpoB2 (zone 2, 453 bp)
(La Scola et al., 2006) were sequenced. All sequences were
1https://www.cdc.gov/epiinfo
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compared with type and reference strains in the GenBank
database2. Appropriate similarity cut-off for reliable species
identification was used (94.0% for gyrB, rpoB1, and rpoB2)
(Adékambi et al., 2008). Supplementary Table S1 shows
the type and reference strains used. The blaOXA-51-like gene
was screened for confirmation of A. baumannii PFGE types
(Woodford et al., 2006).
Multilocus Sequence Typing
Multilocus sequence typing was performed following the
Institute Pasteur protocol3, although the primers used for rpoB
were those described in Villalón et al. (2011). The partial cpn60,
fusA, gltA, pyrG, recA, rplB, and rpoB genes were amplified using
the conditions described by Bartual et al. (2005). Each allelic
profile was assigned an ST.
Antimicrobial Susceptibility and
Carbapenemase Genes
Susceptibility testing for imipenem, meropenem, amikacin,
gentamicin, tobramycin, ciprofloxacin, levofloxacin,
trimethoprim-sulphamethoxazole, and colistin was undertaken
using the MicroScan NM37 microdilution method (Dade
Behring, West Sacramento, CA, United States). E-test strips
(bioMérieux, Marcy-l’Etoile, France) were used to confirm
imipenem resistance. The control strain used was Pseudomonas
aeruginosa ATCC 27853. Results were interpreted using The
European Committee on Antimicrobial Susceptibility Testing for
Acinetobacter spp. (The European Committee on Antimicrobial
Susceptibility Testing, 2017).
The complete blaOXA-51-like gene (825 bp) was
sequenced for all A. baumannii PFGE types; primers 51A
(5′-ATGAACATTAAAGCACTCTTAC-3′) and 51D (5′-
CTATAAAATACCTAATTGTTCT-3′) (Vahaboglu et al., 2006)
amplified the gene; and primers 51A, OXA-51-likeFr&c (5′-
CAAGGCGGATCAAAGCATTA-3′) (Turton et al., 2006) and
OXA-51-OUT2 (5′-CCAAGATGAAGTGCAATCCA-3′) were
used for sequencing (Evans, 2009).
The acquired CHO genes (blaOXA-23-like, blaOXA-40-like,
and blaOXA-58-like), their most commonly associated insertion
sequences (ISAba1, ISAba2, ISAba3, ISAba4, and IS18), and the
MBL genes blaIMP, blaVIM, blaSIM-1, blaGIM-1, blaSPM-1, and
blaNDM-1 were examined for imipenem-resistant PFGE types.
The primers and PCR conditions used are described elsewhere
(Villalón et al., 2013).
Phylogenetic and Clonal Analysis
Sequences were assembled using Lasergene SeqMan II
software (DNA Star, Inc., Madison, WI, United States).
The phylogenetic clustering of gyrB, and rpoB1-rpoB2
concatenated partial sequences was constructed using the
Neighbor-joining method, employing the Jukes-Cantor
algorithm. Bootstrap values were obtained from 1000
resamplings. MLST clustering was represented using the
MST method. Phylogenetic and MLST clustering was performed
2www.ncbi.nlm.nih.gov/
3www.pubmlst.org
using BioNumerics software (version 5.1) (Applied Maths,
Sint-Martens-Latem, Belgium).
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One hundred and one PFGE types were detected among
the 133 Spo isolates collected from the respiratory tract
(51.1% of isolates), wounds (16.5%), urine (8.3%), samples
for screening of A. baumanni carriers (8.3%), environmental
samples (7.5%), blood (5.3%), biliary fluid (0.8%), and ‘not
informed’ samples (2.3%). These isolates came from the
pneumology ward on the third floor (42.9%), wards on the
fourth floor (16.5%), the intensive care unit (10.5%), wards on
the fifth floor (10.5%), the out-patient clinic consultation room
(10.5%), the emergency room (5.3%), wards on the first floor
(1.5%), and “not informed” locations (2.3%). Supplementary
Table S2 shows the epidemiological data collected for all
101 Spo PFGE types.
gyrB, rpoB, and blaOXA-51-like Target
Genes for Molecular Identification of
Acinetobacter Species
Species (number of PFGE types) were identified as: A. baumannii
(67), A. pittii (22), A. lactucae (6), A. calcoaceticus (2),
A. courvalinii (1), A. haemolyticus (1), A. proteolyticus (1), and
A. schindleri (1) (Supplementary Tables S1, S2 shows the results
obtained by all three identification methods).
gyrB-PCR analysis (Higgins et al., 2007, 2010b) identified
all A. baumannii (n = 67) and A. pittii (n = 22) PFGE types.
A. lactucae PFGE types (n = 6) were misidentified: all returned
an 1194 bp fragment and an additional 490 bp fragment
was amplified for Spo100. With respect to A. calcoaceticus
(n = 2), only Spo76 was misidentified since two 194 and
428 bp fragments were obtained. No DNA fragments
were amplified for Acinetobacter species not included in
the Acb complex.
gyrB sequencing returned 54 different sequences, 49 of which
were novel. Comparisons with GenBank-held reference/type
sequences revealed all PFGE types were reliably identified.
The sequencing of rpoB1 and rpoB2 returned 29 and 34
sequences, respectively, 13 and 16 of which were novel. All
PFGE types were correctly identified, except for Spo56; which
rpoB2 sequence shared only 92.8% genetic similarity with the
A. pittii reference strain CIP 70.15 (Adékambi et al., 2008;
Supplementary Table S1).
The novel gyrB, rpoB1, and rpoB2 sequences were each
assigned a GenBank accession number (Supplementary Table
S1). Figure 1 shows the phylogenetic trees of gyrB and the
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concatenated rpoB1-rpoB2 sequences, clustering all PFGE types
into well-defined Acinetobacter species.
The blaOXA-51-like gene was detected for A. baumannii (n = 67),
but not for the non-A. baumannii PFGE types (n = 34).
MLST Clonal Structure of the Sporadic
Population
Sixty-three STs were detected for the 101 PFGE types, 38 of
which were novel: ST687-ST697, ST832, ST833, ST849-ST872,
and ST956. Seven PFGE types could not be typed due to a lack of
PCR-amplification or to the presence of ambiguous nucleotides at
some loci; these included one A. baumannii (Spo23), two A. pittii
(Spo56 and Spo65), and the four non-Acb complex species
identified (Supplementary Table S2). Sixty-six novel alleles were
identified [with 56 (84.8%) among the non-A. baumannii PFGE
types]; 15 for cpn60 (cpn60-127 – cpn60-140 and cpn60-142), 10
for fusA (fusA-126 – fusA-135), nine for gltA (gltA-125 – gltA-
133), five for pyrG (pyrG-68 – pyrG-72), 10 for recA (recA-138 –
recA-147), seven for rplB (rplB-70 – rplB-76), and nine for rpoB
(rpoB-121 – rpoB-129).
The most common STs identified were ST2 (21.8% of isolates)
and ST132 (10.5%). The remainder were represented by under 4%
of isolates. Figure 2 shows the MST displaying the MLST clonal
structure of the Acb complex population.
Susceptibility to Antimicrobial Agents in
Sporadic Population
Most (84.2%) of the Spo PFGE types were susceptible to all
the tested antimicrobial agents. The total resistance rates were
3.0% for imipenem and meropenem, 7.0% for amikacin, 4.0% for
gentamicin, 5.0% for tobramycin, 3.0% for ciprofloxacin, 4.0%
for levofloxacin, 2.0% for trimethoprim-sulphamethoxazole, and
0% for colistin. Multidrug-resistance (MDR) (Magiorakos et al.,
2012) was detected only for Spo1/ST2 and Spo2/ST2.
Exclusively Spo4/ST2, Spo32/ST10, and Spo94/ST15 showed
carbapenem-resistance, but all three were susceptible to
the remaining antimicrobial agents tested. Screening for
acquired carbapenemases detected the genetic structure ISAba2-
blaOXA-58-like-ISAba3. Sequencing of the complete blaOXA-51-like
gene revealed 26 allelic variants (GenBank accession numbers:
KY126220 – KY126241), nine of which are here described for
the first time (OXA-554 to OXA-562). Supplementary Table S2
describes the OXA-51 alleles detected, and Figure 2 shows the
clonal distribution of the most common OXA-51 alleles.
The A. calcoaceticus-A. baumannii
Complex Population: Sporadic vs.
Endemoepidemic
The Spo isolates were most commonly detected in respiratory
samples (p < 0.001), and the EE isolates in the environmental
(p < 0.001) and ICU-location (p = 0.03) samples. In addition, all
the non-A. baumannii PFGE types were sporadic. ST2 was the
most common in both populations, but the distribution of the
other STs differed substantially. The Spo PFGE types returned
a large number of STs, with 47 of the total 63 represented
by one isolate only. In contrast, the EE PFGE types showed
few STs (ST2, ST3, ST15, and ST80) that grouped a larger
number of isolates (103, 80, 38, and 10, respectively) (Figure 2).
Only two Spo PFGE types possessed MDR, while all the EE
PFGE types showed either MDR (23 out of 231 isolates) or
extensively drug-resistance (208 isolates) (Magiorakos et al.,
2012; Villalón et al., 2015).
DISCUSSION
Nosocomial A. baumannii outbreaks are a major problem
worldwide (Maragakis and Perl, 2008; Higgins et al., 2010a).
Other A. calcoaceticus-A. baumannii complex species have been
less frequently involved in epidemics, and have thus been less
studied (Schleicher et al., 2012). Less still is known about the Spo
Acb complex strains (Sonnevend et al., 2013) since these are not
considered a serious public health problem. In this context, the
present analysis contributes significantly toward our knowledge
of the epidemiology and dynamics of the Acb complex as a whole.
Most Spo isolates (82%) were involved in nosocomial
infections. The respiratory tract was confirmed as the most
common site of Acb complex nosocomial infections (Peleg et al.,
2008), although in the present work 51% of Spo and 32% of
EE isolates were obtained from respiratory samples (p < 0.001).
The strict surveillance implemented on the pneumology ward
- affected by one outbreak and by the endemic persistence
of several clones (Villalón et al., 2015) – might explain the
large number of Spo isolates detected in samples of this origin.
In addition, the EE isolates were more commonly retrieved
from environmental samples (p < 0.001), probably because
environmental sampling is routinely performed during outbreaks
(Peleg et al., 2008). Finally, EE strains were more commonly
retrieved from the ICU (the ward most affected by A. baumannii
epidemics) than were Spo strains (p = 0.03).
Acinetobacter baumannii was the major species detected
among the Spo PFGE types, followed by A. pittii, A. lactucae,
and A. calcoaceticus. However, other important species like
A. nosocomialis, A. seifertii, and Acinetobacter gen. species
“between 1 and 3” were absent. Further, A. baumanni was the
only species detected among the EE PFGE types (Villalón et al.,
2015). These results agree with A. baumannii to be the species
of the Acb complex mainly involved in either outbreaks or Spo
infections (Peleg et al., 2008).
The gyrB multiplex PCR analysis was designed to differentiate
A. baumannii, A. calcoaceticus, A. nosocomialis, and A. pittii
(Higgins et al., 2007, 2010b) only. A. baumannii and A. pittii
PFGE types were correctly identified, but one out of two
A. calcoaceticus (Spo76), and all of the A. lactucae PFGE types,
were misidentified. The results were expected except for Spo76.
Matching of the gyrB sequences with those in databases
identified all PFGE types correctly. The identification of
A. lactucae was more troublesome than the other species
due to the lack of gyrB reference entries. We also detected
wrong identifications in GenBank database, like actual A.pittii
misidentified as A. calcoaceticus, and actual A. lactucae
misidentified as A. pittii; it should be considered in this kind of
analyses. However, all but one PFGE type were reliably identified
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FIGURE 1 | Clustering of Acinetobacter species. Phylogenetic trees obtained from the alignment of (A) partial gyrB gene sequences and (B) rpoB1-rpoB2
concatenated partial sequences. The trees were inferred by the Neighbor-joining method. Non-Acinetobacter calcoaceticus-A. baumannii complex PFGE types
formed the outgroup to root the tree. Branches were supported by 1000 resamplings. Bootstrap values of ≥70% are indicated above branches. Minimum
intraspecies similarity values (%) are shown below branches. The A. baumannii branch includes sporadic (Spo) and endemoepidemic (EE) PFGE types and is
collapsed owing to its complexity. The bar indicates 1% genetic divergence. The total number of PFGE types (n) identified for each Acinetobacter species was
calculated excluding the type (T) strains included in the analysis.
by rpoB1 and rpoB2 sequencing. gyrB sequencing has slight
disadvantages compared to rpoB1- and rpoB2-sequencing: the
lack of database for A. lactucae and the extra work required
to sequence the larger genetic fragment. Both rpoB1 and rpoB2
analyses seem able to accurately identify Acinetobacter species,
but rpoB1 fragment is shorter, making its use more practical
(La Scola et al., 2006). Finally, phylogenetic analysis of the gyrB
and rpoB1-rpoB2 concatenated sequences showed monophyletic
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clustering for each species of the Acb complex (Figure 1), which
reflects the excellent discrimination power for both methods.
Given the present results, the PCR-amplification of gyrB is
here proposed as a first step in the molecular identification of
Acb complex members, because it efficiently identifies at least
two of the most frequent species -A. baumannii, and A. pittii-. If
the results obtained are not conclusive, the sequencing of rpoB1,
rpoB2, and the partial gyrB gene should be performed in the order
described. If sequence-matching with information in databases
fails to provide reliable results, a final phylogenetic analysis
should be performed to make definitive species identifications.
In the present study, we have purposely undertaken the
identification at the species level using molecular methods only,
and we have shown the complexity of such identification
due to the close genetic relatedness of members of the
Acb complex in particular when trying to differentiate
between A. pittii and A. lactucae. However, A. nosocomialis
and A. seifertii were not isolated in this setting, and it
was not possible to check if similar difficulty also affected
differentiation of these two closely related species. We are
aware that the recent implementation of MALDI-TOF/MS
has recently been shown to solve some of these issues but
such technology is not yet easily available to all routine
clinical laboratories.
The MLST clonal structure of the Acb complex grouped the
four identified species into different clusters (Figure 2). The
Acb complex Spo population was highly diverse, with a large
number of STs mostly represented by single isolates. Other
authors have also described this variability in Spo clones (Karah
et al., 2012; Sonnevend et al., 2013; Tomaschek et al., 2016). The
A. baumannii Spo population grouped into 37 STs, with ST2
and ST132 the most prevalent. The international clonal complex
CC2 was represented by ST2 and ST697, and carried the OXA-
66 allele (blaOXA-51-like gene). CC132 was mainly represented by
ST132 and carried the OXA-120 allele. The number of isolates
and its distribution from 2000 to 2009 suggest that ST132 should
be monitored for the emergence of greater resistance. Other
international CCs detected in Spo isolates were represented by
ST15 and ST10. Some OXA-51 alleles were detected that were
not always linked to a specific CC (Pournaras et al., 2014):
OXA-555 was carried by ST15 and by other non-related STs,
and OXA-120 was detected in three STs not included in CC132
(Figure 2). The A. pittii population showed only two small
CCs, one with ST64 as the most common ST. A. lactucae and
A. calcoaceticus grouped into no CCs. The A. baumannii EE
PFGE types, in contrast, grouped into four STs (ST2, ST3, ST15,
and ST80: Figure 2), each represented by a large number of
isolates (Villalón et al., 2015).
OXA-58, one of the main CHOs in A. baumannii in Spain
(Villalón et al., 2013; Nowak et al., 2017), was responsible for
the detected resistance to imipenem in Spo clones. MDR and
carbapenem resistance was associated to the international ST2,
ST10, and ST15 (Diancourt et al., 2010). Antimicrobial resistance
and other virulence factors contribute to the epidemicity of
the strains (Selasi et al., 2016). In this study, resistance and
epidemicity are closely related and so, the presence of Spo
resistant clones in the hospital setting could be a risk for future
outbreaks (Fournier and Richet, 2006; Sonnevend et al., 2013).
In regards to the EE clones; ST2 belongs to the international
CC2, the most frequent in many European countries, and notably
in the Mediterranean area. The high presence of ST2 conditioned
its majority in Spo isolates. ST3 is the main representative
FIGURE 2 | Minimum spanning tree showing the multilocus sequence typing (MLST) clonal structure of the Acb complex population. Circles represent the different
STs; the size is proportional to the number of isolates. The connecting lines indicate the distance between STs, coded according to the number of locus variants.
Dotted lines group the STs into Acinetobacter species. The clonal complexes are shadowed and cluster STs with a maximum of one different locus. Spo STs are
represented in white. Colored STs include EE and Spo isolates (numbers and percentages indicated). The most representative OXA-51 alleles are shown for the
A. baumannii group. CC, clonal complex; ST, sequence type; NA, not assigned; T, type strain; Spo, sporadic; EE, endemoepidemic.
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of the international CC3; its global distribution is lesser than
international CC1 and CC2, but in Spain it has been more
frequently isolated than the CC1. ST15 belongs to another
international clonal lineage and has an intermediate distribution
in Europe. ST80 was first described in Spain where was involved
in some nosocomial outbreaks, but it has not been described as an
international clonal lineage at the moment (Higgins et al., 2010a;
Villalón et al., 2011; Karah et al., 2012; Castanheira et al., 2014;
Tomaschek et al., 2016; Dahdouh et al., 2017; Nowak et al., 2017).
Resistance to carbapenems was common in EE clones and
it was due to the presence of blaOXA-40-like, and blaOXA-58-like
genes. OXA-40 and OXA-58 were the most frequent CHOs
detected in A. baumannii in Spain during the period 1999–
2010, which is in excellent agreement with the epidemiology
and the main mechanisms of carbapenem resistance detected
in our isolates, also recovered within the same time frame.
Nevertheless, in 2013 the first isolate carrying blaOXA-23-like
was detected in our country and its presence has gradually
increased ever since (Espinal et al., 2013; Mosqueda et al.,
2013; Dahdouh et al., 2017). Currently, the replacement
of blaOXA-40-like by blaOXA-23-like could be happening as it
was previously described in Portugal (Grosso et al., 2011).
Unfortunately, it was not possible to include in our study isolates
recovered after 2011 and, therefore, we could not evaluate the
impact of recent changes in the epidemiology of Acinetobacter
in Spain on the dynamics of EE and Spo clones in this
particular setting.
In conclusion, the Spo Acb complex population examined was
diverse, though it was mainly composed of A. baumannii. The
clonal structure reflected many different clones, although none
but CC2 was clearly dominant. Most clones were susceptible to
antimicrobial agents; MDR was very rare. On the other hand, the
EE Acb population was more homogeneous, made up of a few
expanding A. baumannii CCs showing MDR.
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